ScreenerHero

LABS MediPharm Labs Corp.

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · medipharmlabs.com
0.0700CAD0.00%Mkt Cap: 21.78M $P/E: —

MediPharm Labs Corp. operates as a pharmaceutical company that produces and sells purified, pharmaceutical-like cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Cana…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap21.78M USD
Enterprise Value14.49M USD
Revenue (TTM)30.19M USD
Gross Profit10.17M USD
Net Income (TTM)-6.02M USD
Revenue/Share0.10 CAD
Last Price0.0700 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees127
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58504D1006
Valuation
P/E (Trailing)—
P/E (Forward)-7.00
PEG—
EV/EBITDA-8.25
EV/Revenue0.48
P/S0.72
P/B0.84
EPS (TTM)-0.01
EPS (Forward)-0.01
52W Range
0.060025% of range0.1000
52W High0.1000 CAD
52W Low0.0600 CAD
Profitability
Gross Margin30.95%
Oper. Margin0.82%
EBITDA Margin-5.82%
Profit Margin-18.32%
ROE-23.08%
ROA-18.07%
Growth
Revenue Growth-15.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.01M USD
CapEx (TTM)72.83K USD
FCF Margin4.97%
FCF Yield6.88%
Net Debt-7.28M USD
Net Debt/EBITDA4.15
Balance Sheet
Debt/Equity0.01
Current Ratio2.69
Quick Ratio1.68
Book Value/Sh0.08 CAD
Cash/Share0.02 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.427.18M
Float390.00M
Insiders11.64%
Institutions0.00%
Short Interest
Short Ratio2.2d
Short % Out.0.06%
Shares Short270.41K
Short (prev mo.)198.26K
Technical
SMA 500.0744 (-5.9%)
SMA 2000.0725 (-3.5%)
Beta0.93
S&P 52W Chg14.58%
Avg Vol (30d)145.72K
Avg Vol (10d)136.18K
Technical Indicators
RSI (14)43.2
MACD-0.0015
MACD Signal-0.0012
MACD Hist.-0.0003
BB Upper0.0776 CAD
BB Middle0.0725 CAD
BB Lower0.0674 CAD
BB Width14.15%
ATR (14)0.0033 CAD
Vol Ratio (20d)0.11x